Skip to content

Creating a Diagnostic Decision Rule for Shoulder Injury: CASH-trial

Creating a Diagnostic Decision Rule for Shoulder Injury: CASH-trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02857439
Acronym
CASH
Enrollment
280
Registered
2016-08-05
Start date
2016-07-31
Completion date
2018-07-31
Last updated
2016-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Keywords

Trauma of the shoulder

Brief summary

What combination of ≤ 6 clinical variables will give the highest specificity for indicating significant shoulder injuries (fractures or dislocations) with a set sensitivity of ≥ 97%? Although shoulder trauma is a common injury, there is no clinical decision rule to determine the necessity for radiography for these traumas. With this trial the investigators aim to develop such a rule to reduce the amount of radiographs without missing any significant injuries. The primary objective is to compose a set of clinical diagnostic criteria predictive of shoulder fractures or dislocations that would reduce the amount of radiographs without missing any significant injuries. A second objective is to determine if the clinical decision rule is applicable for triage use.

Detailed description

The CASH (Clavicle-AC-Joint-Sub-capital-Humerus) trial is designed as a cross sectional interobserver study. It will randomize between first examiner of the patient to determine applicability for triage use and use a list of 19 criteria to determine a clinical decision rule for significant shoulder injuries. Method/intervention After admittance to the ED, all consecutive shoulder injury patients will be assessed for eligibility in the study. After informed consent is given, the patient will be randomized for first observer (ED physician or triage nurse) to be examined, which means they will be assessed in duplo. The patient will be examined by means of a score form, which contains 19 different diagnostic criteria. The criteria are grouped: anamnesis, inspection, palpation and pain/range of motion(ROM). After completing the list, patients will get a full set of shoulder x-rays: shoulder AP- and axial-view, and clavicle AP and 30' cranio-caudal view. The trial participation for the patient will be completed at this point and final diagnosis and treatment are provided by the ED physician according to his/her own findings and interpretation of the radiographs. For the study, the radiographs will be reassessed by one consultant radiologist specialized in skeletal trauma.

Interventions

OTHERStandard diagnostic item list

All consecutive patients are assessed by both examiners, according to a standardized physical examination item list.

Sponsors

Zaans Medisch Centrum
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Aged18-65 years * Trauma \<48h

Exclusion criteria

* Any prior ipsilateral shoulder surgery. * Any diseases of the bones potentially influencing fracturability (osteogenesis imperfecta, osteoporosis, achondroplasia, M. Kahler, chronic (\> 1yr) prednisone use \> 5mg) * Any shoulder injury as part of a multi-trauma or high energy trauma (HET) with distractible injuries * Any condition that will influence the perception of pain (e.g. alcohol intoxication, psychiatric problems, mental retardation)

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy (sensitivity and specificity) of the clinical variables assessed with the score form.An average of 12 to 18 months

Secondary

MeasureTime frame
Interobserver agreement for each clinical variable between both observers determined with the Cohen's kappa coefficientAn average of 12 to 18 months

Countries

Netherlands

Contacts

Primary ContactRobert Jan Derksen, MD
Derksen.R@zaansmc.nl
Backup ContactKim Rijsbergen, BSc
Rijsbergen.K@zaansmc.nl

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026